Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeRediscovering ACE: novel insights into the many roles of the angiotensin-converting enzymeReduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren SyndromeHow the kidney is impacted by the perinatal maternal environment to develop hypertensionAngiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domainDevelopment of an automated imaging pipeline for the analysis of the zebrafish larval kidneyDrug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial.Perinatal Na+ overload programs raised renal proximal Na+ transport and enalapril-sensitive alterations of Ang II signaling pathways during adulthood.Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia.Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland.Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literatureThe relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia.Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancyTherapeutic approach to FSGS in children.The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor BlockersTaking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?Postnatal acute renal failure after fetal exposure to angiotensin receptor blockersPlacental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in rats.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.Hypertension guidelines: thresholds, targets, and teratogenicityAntihypertensive medication use during pregnancy and the risk of cardiovascular malformations.Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome.Neonatal acute kidney injury following Valsartan exposure in utero: report of two cases.Contraceptive methods and informed consent among women receiving medications with potential for adverse fetal effects: a Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region studyAbsence of cell surface expression of human ACE leads to perinatal death.Antihypertensive Peptides from Milk ProteinsMigraine therapy during pregnancy and lactation.Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies.Pharmacogenetics of drug-induced birth defects: what is known so far?Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery.New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor.Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.Hypertension in pregnancy: natural history and treatment options.Prenatal exposure to angiotensin II increases blood pressure and decreases salt sensitivity in rats.Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.Salvianolic acid B and danshensu induce osteogenic differentiation of rat bone marrow stromal stem cells by upregulating the nitric oxide pathway.Association between polymorphisms in the renin-angiotensin system genes and prevalence of spontaneously aborted fetuses.
P2860
Q24306614-AC999EC9-85BF-457C-9F4B-F2C701BF0677Q27004277-C4E4972C-EF95-4580-898E-9848BAF75E97Q27335096-CF1EAA5A-1E96-4047-A158-F85CB7A4F82BQ28389052-9A99A2C6-9FC5-4BD5-90B0-859A1EDFD050Q28473818-AEB82A14-FC65-46FB-B4E7-DAC7A6AAC334Q28661285-802DDA3D-E6FF-498E-A7C5-1F399B95FFF5Q34051477-391C4D69-EC9F-44AE-A6D9-9AF04AECA011Q34285287-B7796898-076C-438B-A5C6-233A92F647AAQ34396018-665BD83E-8E8F-449E-BE24-2E973D8A7218Q34424588-D1B57052-6D13-4C4A-A96C-2956E50B9EB8Q34609043-B787D9B2-2045-4F62-8E4D-A6574012EA1EQ35573768-647AF2E3-6D31-490A-BDE2-AEE3ABB7B914Q35591704-7350EC40-CE39-49D9-97C2-FA4D404CF3B1Q35596724-E1E42BA8-5DE1-4C79-B0E8-EDABAD797F2EQ35614311-2039E437-8CC8-4633-8082-2E2EDEEDC593Q35615160-98C7AB3E-E5B6-46B2-B137-D1E68F23ED66Q35688666-936A6A0E-5F6E-42BE-BCFE-CF39DE1D6024Q35823635-EBFCF77C-323A-4BEB-9D41-3AB5AAD006F9Q36086272-E5D38BDB-64E2-4E67-8077-16BEE820E157Q36565036-FBC78186-DC9C-4D74-895D-BB9F16BA013CQ36620242-27E54BB0-E049-4AC5-BC66-4EE480BDA990Q36793874-E05F71AE-D11D-48DD-82A8-24849C56A2D1Q37020820-444310BA-825B-4E72-A51E-15755275D691Q37174744-46BBFB77-CFC0-412B-911B-6B2963B68C28Q37357631-BAB26AD6-6696-47C6-B204-C4AB45830954Q37465204-F7AAB62E-248C-4634-AA9E-5796D380D306Q37593031-9DCCB00E-2D8D-408D-B525-16403A782AECQ37709455-461E5267-68E2-44DE-8BCC-16949565AEA0Q37775960-0F57A99C-BFA3-4C9A-BD62-F2F3FE6E8E21Q37861890-F9C536EB-492E-42E8-AB3D-35BDA4F8E3ADQ37869124-1681DC24-CA87-423A-9FE9-A3B6DE6FC69AQ38027126-897ECAD0-248C-45D2-B6A5-55E1E270AE52Q38089817-7E772322-DB59-4954-9F6B-71EBA02E112DQ38127847-F7CA5759-E54E-4300-B683-0AB5CF2737D5Q38360765-48F79A62-4B31-4C7F-86EA-B750E1329ED1Q38400715-64C24CFD-2B79-4EF6-BF3A-0326F2062915Q38665212-40C2CD9D-53C8-40B5-A715-F4E047318B12Q40113622-C2673AA4-EBCF-466C-B69F-2C56226EC2C3Q42364665-0C37A680-1701-4315-92B1-9A10E8F48087Q43581806-86CB2B2C-2C67-41E8-8950-D7847882F97B
P2860
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Fetopathy associated with expo ...... iotensin receptor antagonists.
@ast
Fetopathy associated with expo ...... iotensin receptor antagonists.
@en
type
label
Fetopathy associated with expo ...... iotensin receptor antagonists.
@ast
Fetopathy associated with expo ...... iotensin receptor antagonists.
@en
prefLabel
Fetopathy associated with expo ...... iotensin receptor antagonists.
@ast
Fetopathy associated with expo ...... iotensin receptor antagonists.
@en
P1476
Fetopathy associated with expo ...... iotensin receptor antagonists.
@en
P2093
Albert Quan
P356
10.1016/J.EARLHUMDEV.2005.11.001
P577
2006-01-19T00:00:00Z